Cargando…
Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy
CONTEXT: The effects of androgen therapy on arterial function in transgender men (TM) are not fully understood, particularly concerning long-term androgen treatment. OBJECTIVE: To evaluate arterial stiffness in TM receiving long-term gender-affirming hormone therapy by carotid–femoral pulse wave vel...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096903/ https://www.ncbi.nlm.nih.gov/pubmed/37063700 http://dx.doi.org/10.1210/jendso/bvad040 |
_version_ | 1785024450592243712 |
---|---|
author | Cunha, Flávia Siqueira Bachega, Tania Aparecida Sartori Sanchez Costa, Elaine Maria Frade Brito, Vinicius Nahime Alvares, Leonardo Azevedo Costa-Hong, Valéria Aparecida Verardino, Renata Gomes Sanches Sircili, Maria Helena Palma de Mendonça, Berenice Bilharinho Bortolotto, Luiz Aparecido Domenice, Sorahia |
author_facet | Cunha, Flávia Siqueira Bachega, Tania Aparecida Sartori Sanchez Costa, Elaine Maria Frade Brito, Vinicius Nahime Alvares, Leonardo Azevedo Costa-Hong, Valéria Aparecida Verardino, Renata Gomes Sanches Sircili, Maria Helena Palma de Mendonça, Berenice Bilharinho Bortolotto, Luiz Aparecido Domenice, Sorahia |
author_sort | Cunha, Flávia Siqueira |
collection | PubMed |
description | CONTEXT: The effects of androgen therapy on arterial function in transgender men (TM) are not fully understood, particularly concerning long-term androgen treatment. OBJECTIVE: To evaluate arterial stiffness in TM receiving long-term gender-affirming hormone therapy by carotid–femoral pulse wave velocity (cf-PWV). METHODS: A cross-sectional case–control study at the Gender Dysphoria Unit of the Division of Endocrinology, HC-FMUSP, Sao Paulo, Brazil. Thirty-three TM receiving intramuscular testosterone esters as regular treatment for an average time of 14 ± 8 years were compared with 111 healthy cisgender men and women controls matched for age and body mass index. Aortic stiffness was evaluated by cf-PWV measurements using Complior device post-testosterone therapy. The main outcome measure was aortic stiffness by cf-PWV as a cardiovascular risk marker in TM and control group. RESULTS: The cf-PWV after long-term testosterone therapy was significantly higher in TM (7.4 ± 0.9 m/s; range 5.8-8.9 m/s) than in cisgender men (6.6 ± 1.0 m/s; range 3.8-9.0 m/s, P < .01) and cisgender women controls (6.9 ± .9 m/s; range 4.8-9.1 m/s, P = .02). The cf-PWV was significantly and positively correlated with age. Analysis using blood pressure as a covariate showed a significant relationship between TM systolic blood pressure (SBP) and cf-PWV in relation to cisgender women but not to cisgender men. Age, SBP, and diagnosis of hypertension were independently associated with cf-PWV in the TM group. CONCLUSION: The TM group on long-term treatment with testosterone had higher aging-related aortic stiffening than the control groups. These findings indicate that aortic stiffness might be accelerated in the TM group receiving gender-affirming hormone treatment, and suggest a potential deleterious effect of testosterone on arterial function. Preventive measures in TM individuals receiving testosterone treatment, who are at higher risk for cardiovascular events, are highly recommended. |
format | Online Article Text |
id | pubmed-10096903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-100969032023-04-13 Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy Cunha, Flávia Siqueira Bachega, Tania Aparecida Sartori Sanchez Costa, Elaine Maria Frade Brito, Vinicius Nahime Alvares, Leonardo Azevedo Costa-Hong, Valéria Aparecida Verardino, Renata Gomes Sanches Sircili, Maria Helena Palma de Mendonça, Berenice Bilharinho Bortolotto, Luiz Aparecido Domenice, Sorahia J Endocr Soc Clinical Research Article CONTEXT: The effects of androgen therapy on arterial function in transgender men (TM) are not fully understood, particularly concerning long-term androgen treatment. OBJECTIVE: To evaluate arterial stiffness in TM receiving long-term gender-affirming hormone therapy by carotid–femoral pulse wave velocity (cf-PWV). METHODS: A cross-sectional case–control study at the Gender Dysphoria Unit of the Division of Endocrinology, HC-FMUSP, Sao Paulo, Brazil. Thirty-three TM receiving intramuscular testosterone esters as regular treatment for an average time of 14 ± 8 years were compared with 111 healthy cisgender men and women controls matched for age and body mass index. Aortic stiffness was evaluated by cf-PWV measurements using Complior device post-testosterone therapy. The main outcome measure was aortic stiffness by cf-PWV as a cardiovascular risk marker in TM and control group. RESULTS: The cf-PWV after long-term testosterone therapy was significantly higher in TM (7.4 ± 0.9 m/s; range 5.8-8.9 m/s) than in cisgender men (6.6 ± 1.0 m/s; range 3.8-9.0 m/s, P < .01) and cisgender women controls (6.9 ± .9 m/s; range 4.8-9.1 m/s, P = .02). The cf-PWV was significantly and positively correlated with age. Analysis using blood pressure as a covariate showed a significant relationship between TM systolic blood pressure (SBP) and cf-PWV in relation to cisgender women but not to cisgender men. Age, SBP, and diagnosis of hypertension were independently associated with cf-PWV in the TM group. CONCLUSION: The TM group on long-term treatment with testosterone had higher aging-related aortic stiffening than the control groups. These findings indicate that aortic stiffness might be accelerated in the TM group receiving gender-affirming hormone treatment, and suggest a potential deleterious effect of testosterone on arterial function. Preventive measures in TM individuals receiving testosterone treatment, who are at higher risk for cardiovascular events, are highly recommended. Oxford University Press 2023-03-17 /pmc/articles/PMC10096903/ /pubmed/37063700 http://dx.doi.org/10.1210/jendso/bvad040 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Research Article Cunha, Flávia Siqueira Bachega, Tania Aparecida Sartori Sanchez Costa, Elaine Maria Frade Brito, Vinicius Nahime Alvares, Leonardo Azevedo Costa-Hong, Valéria Aparecida Verardino, Renata Gomes Sanches Sircili, Maria Helena Palma de Mendonça, Berenice Bilharinho Bortolotto, Luiz Aparecido Domenice, Sorahia Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy |
title | Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy |
title_full | Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy |
title_fullStr | Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy |
title_full_unstemmed | Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy |
title_short | Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy |
title_sort | arterial stiffness in transgender men receiving long-term testosterone therapy |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096903/ https://www.ncbi.nlm.nih.gov/pubmed/37063700 http://dx.doi.org/10.1210/jendso/bvad040 |
work_keys_str_mv | AT cunhaflaviasiqueira arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT bachegataniaaparecidasartorisanchez arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT costaelainemariafrade arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT britoviniciusnahime arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT alvaresleonardoazevedo arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT costahongvaleriaaparecida arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT verardinorenatagomessanches arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT sircilimariahelenapalma arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT demendoncaberenicebilharinho arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT bortolottoluizaparecido arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy AT domenicesorahia arterialstiffnessintransgendermenreceivinglongtermtestosteronetherapy |